Copyright
©The Author(s) 2019.
World J Gastroenterol. Mar 21, 2019; 25(11): 1409-1420
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1409
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1409
Figure 1 Study design.
GFD: Gluten-free diet; GSRS: Gastrointestinal Symptom Rating Scale.
Figure 2 Summary of outcome of patients enrolled, and samples received and analyzed according to clinical status.
GFD: Gluten-free diet; GIP: Gluten immunogenic peptides; CeD: Celiac disease; PoCT: Point-of-care tests; ELISA: Enzyme-linked immunosorbent assay.
- Citation: Costa AF, Sugai E, Temprano MLP, Niveloni SI, Vázquez H, Moreno ML, Domínguez-Flores MR, Muñoz-Suano A, Smecuol E, Stefanolo JP, González AF, Cebolla-Ramirez A, Mauriño E, Verdú EF, Bai JC. Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patients. World J Gastroenterol 2019; 25(11): 1409-1420
- URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1409.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i11.1409